Citigroup’s ERBA DIAGNOSTICS ERB Stock Holding History

Citigroup’s Portfolio ERB Stock Details ERB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6	Closed	–	–	7981
2015 Q1	$0	Buy	+6	New	+$21	﹤0.01%	7642
2014 Q1	–	Sell	-358	Closed	-$1K	–	7355
2013 Q4	$1K	Buy	+358	New	+$681	﹤0.01%	6918

Other funds holding ERB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Citigroup's ERB Position: Q2 2015 in Review

Citigroup sold out of ERBA DIAGNOSTICS (ERB) in Q2 2015, closing a stake of 6 shares.

Citigroup first reported a position in ERB in Q4 2013 and held it in 2 quarters. The position peaked at $1K in Q4 2013. 16 funds tracked by Wall St. Rank hold ERB as of Q2 2015.

Citigroup reported no remaining ERBA DIAGNOSTICS position as of Q2 2015 after selling out during the quarter.
Citigroup sold 6 ERBA DIAGNOSTICS shares in Q2 2015.
Citigroup first reported a position in ERBA DIAGNOSTICS in Q4 2013 and held it in 2 quarters.
Citigroup's ERBA DIAGNOSTICS position peaked at $1K in Q4 2013.
16 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.